Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Injectable Therapy May Avert Rotator Cuff Injuries

By HospiMedica International staff writers
Posted on 25 Dec 2013
An injectable compound under development could inhibit the breakdown of the supraspinatus tendon, a rotator cuff tendon that is commonly torn in sports. More...


Researchers at Georgia Tech (Atlanta, USA) and Emory University (Atlanta, GA, USA) are conducting a study to develop improved regenerative medicine strategies to aid repair of tendinopathic tissues. Since one of the hallmarks of tendinopathy is disruption of extracellular matrix (ECM), and particularly collagen, the researcher set out to test which classes of ECM proteases are involved in the tissue degeneration, and develop treatments to deliver inhibitory agents for these enzymes to reduce pathology progression and improve healing.

The central hypothesis of the researchers is that long-term regulation of protease activity in tendinopathy using a protease inhibitor will result in greater tendon tissue structure and mechanical properties. To do so, proteases and inhibitors related to ECM degradation will be tested in vivo in a rat supraspinatus tendon overuse model. The researchers hope to develop a controlled, injectable carrier to achieve local, sustained release of protease inhibitors. The researchers will also study the histology and mechanics of the tendons after healing.

“Normally people focus on treating tendon injuries after the tear has occurred, but we’re focusing on a much earlier stage in the disease,” said lead researcher associate professor Johnna Temenoff, PhD, of the department of Biomedical Engineering. “This is the first time that an injectable therapy specifically designed to interact with tissue at an early disease state has been attempted for this particular tendon injury.”

“We’re studying enzymes that are known to chew up the collagen, and we’re looking at then delivering inhibitors to those enzymes in a local injection in the tendon to try to stop the degradation,” added Dr. Temenoff. “We’re studying the disease in the shoulder, but it’s the same disease that causes tennis elbow, Achilles injuries, and jumper’s knee. It’s the same process, just in different tendons in the body.”

Tendinopathy is a common disorder resulting from repetitive motion in the workplace or during athletic activity that can cause severe pain and long-term disability due to tendon damage in the rotator cuff, a collation of four tendons made of collagen.

Related Links:

Georgia Tech
Emory University



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.